ETFMG Alternative Harvest ETF
What Analysts Estimate for Cannabis Companies’ Earnings Margins
Let’s now look at how capacity expansion could translate into cannabis companies’ margins.
Considerations for Investors in Marijuana or Cryptocurrencies
The forecasting of future cash flows depends on the market potential for legalized medical and recreational marijuana.
A Look at 2 New Marijuana ETFs that Debuted Last Week
While marijuana stocks (MJX) ended in the negative territory week-over-week last week, two new marijuana sector-specific ETFs debuted.
How Canopy Growth’s Margins Looked in 3Q18
During 3Q18, Canopy Growth reported a non-GAAP (generally accepted accounting principles) gross margin of 58% of sales.
Why Scotts Miracle-Gro Stock Fell 14% on January 30
On Tuesday, January 30, 2018, Scotts Miracle-Gro (SMG) reported its 1Q18 earnings with a GAAP loss per share of $0.35. The stock took a significant beating and fell 14%.
Canopy Growth’s Recreational Marijuana Sales Channel
Canopy Growth stated that the Canadian provinces of Ontario and New Brunswick announced that the retail and distribution of recreational marijuana would be overseen by their liquor control boards.
Why the Marijuana Wave May Not Be the Same as Cryptocurrency
In 2018, two investment waves set the market ablaze—marijuana and cryptocurrencies. Although cryptocurrencies have slid since early January, the marijuana wave has held up so far.
Aurora Cannabis’s Reach and the CanniMed Acquisition
In our series Must-Knows before Investing in the Marijuana Industry, we saw how, globally, the acceptance of marijuana has evolved, with more countries either legalizing cannabis access at a federal level or exploring the possibility of legalizing cannabis.
Aurora Cannabis Acquires CanniMed Therapeutics
The marijuana space is already heating up with mergers and acquisitions ahead of recreational marijuana legalization expected in Canada later this year.
Who Will Be the Biggest Players in the Marijuana Space?
With the marijuana sector heating up in Canada lately, we know that several existing and new companies will be rushing to capitalize on the opportunity.
How Wall Street Is Taking an Interest in the Marijuana Industry
Marijuana is still classified as a Schedule 1 drug in the United States and is illicit under federal law. This has created several issues for businesses.